Skip to main content
An official website of the United States government

Artificial Intelligence Dual-Stain Approach Improved Accuracy, Efficiency of Cervical Cancer Screening

, by NCI press release

A slide from an automated dual-stain cytology test. The percentages are AI-generated likelihoods of positive results. The image at center (labeled 98.75%) shows a positive result.

Credit: Nicolas Wentzensen, M.D., Ph.D.

In a new study, a computer algorithm improved the accuracy and efficiency of cervical cancer screening compared with cytology (Pap test), the current standard for follow-up of women who test positive with primary human papillomavirus (HPV) screening. The new approach uses artificial intelligence (AI) to automate dual-stain evaluation and has clear implications for clinical care.

Findings from the study were published June 25, 2020, in the Journal of the National Cancer Institute. The algorithm was developed and the study conducted by investigators at the National Cancer Institute (NCI), part of the National Institutes of Health, in collaboration with researchers from several other institutions.

"We're excited to show we have a fully automated approach to cervical cancer screening as a follow-up to a positive HPV test that outperformed the standard method in our study," said Nicolas Wentzensen, M.D., Ph.D., of NCI's Division of Cancer Epidemiology and Genetics, who led the study. "Based on our results, it could increase the efficiency of cervical cancer screening by finding more precancers and reducing false positives, which has the potential to eliminate a substantial number of unnecessary procedures among HPV-positive women."

Read the complete NCI press release.

Wentzensen N, et al. Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer Screening. J Natl Cancer Inst. June 25, 2020. doi: 10.1093/jnci/djaa066

< Older Post

Robert Hoover Retires Leaving a Legacy of Cancer Epidemiology Research

Newer Post >

2020 Virtual AACR Annual Meeting Features DCEG Research

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Artificial Intelligence Dual-Stain Approach Improved Accuracy, Efficiency of Cervical Cancer Screening was originally published by the National Cancer Institute.”